Orthofix Medical Q3 2026 Results: Net Loss of $6.07M, Loss Narrows
Orthofix Medical Inc. reported net sales of $207.9 million for the third quarter of 2026, a slight increase from $205.6 million in the prior year period. The company achieved a quarterly operating income of $1.5 million, a significant improvement from the $17.0 million operating loss in Q3 2025, though it still recorded a net loss of $6.1 million for the quarter.
- Key figure
- Net loss $6.07M